KIAA0101 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a full length recombinant KIAA0101.
- 产品详情
- 文献引用 : 1
- 实验流程
Application ![]()
| WB, IHC, IF, E |
---|---|
Primary Accession | Q15004 |
Other Accession | BC005832 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG1 Kappa |
Clone Names | 3C11-1F11 |
Calculated MW | 11986 Da |
Gene ID | 9768 |
---|---|
Other Names | PCNA-associated factor, Hepatitis C virus NS5A-transactivated protein 9, HCV NS5A-transactivated protein 9, Overexpressed in anaplastic thyroid carcinoma 1, OEATC-1, PCNA-associated factor of 15 kDa, PAF15, p15PAF, KIAA0101, NS5ATP9, PAF |
Target/Specificity | KIAA0101 (AAH05832, 1 a.a. ~ 111 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IHC~~1:100~500 IF~~1:50~200 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | KIAA0101 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.

Provided below are standard protocols that you may find useful for product applications.
REFERENCES
1.p15PAF Is an Rb/E2F-Regulated S-Phase Protein Essential for DNA Synthesis and Cell Cycle Progression.Chang CN, Feng MJ, Chen YL, Yuan RH, Jeng YMPLoS One. 2013 Apr 4;8(4):e61196. doi: 10.1371/journal.pone.0061196. Print 2013.2.Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.Shubbar E, Kovacs A, Hajizadeh S, Parris TZ, Nemes S, Gunnarsdottir K, Einbeigi Z, Karlsson P, Helou K.BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.3.Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M.Lung Cancer. 2011 Jun 18. [Epub ahead of print]4.Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma.Yuan RH, Jeng YM, Pan HW, Hu FC, Lai PL, Lee PH, Hsu HC.Clin Cancer Res. 2007 Sep 15;13(18):5368-76.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.